Published 31 March 2016 Researchers at Lund University in Sweden have found a new type of biomarker that can predict the risk of type 2 diabetes, by detecting epigenetic changes in specific genes through a simple blood test. “This could motivate a person at risk to change their lifestyle”, says Karl Bacos, researcher in epigenetics at Lund University. The results are published today in Nature Comm

https://www.ludc.lu.se/article/new-method-measures-risk-type-2-diabetes-blood - 2025-04-01

Published 26 January 2021 Lawyer Erik Sjöman, Malmö, was elected as new chairman. At ACLU's annual meeting on January 26th, senior professor Boel Flodgren, who has been chairwoman of the centre since the start, was thanked for her service to the centre. As a leading initiator during ACLU's inaugural year, Boel has been an invaluable pillar with her knowledge, experience and competence. She will no

https://www.aclu.lu.se/en/article/new-chairman - 2025-04-01

Published 23 March 2023 Niklas Arvidsson and Johan Adestam have written a book with the title "Associationsrättens grunder" Författare: Niklas Arvidsson & Johan Adestam Publication year: 2022 Publishing house: Studentlitteratur Introduction (swedish) En betydande del av näringslivet och civilsamhället bedrivs av och i olika slags associationer. Associationsrätt handlar om de regler som möjliggör o

https://www.aclu.lu.se/en/article/new-book-associationsrattens-grunder - 2025-04-01

Published 26 January 2023 Attorney Erik Sjöman is appointed an honorary doctorate at the Faculty of Law. ACLU:s ordförande Erik Sjöman utses till hedersdoktor vid Juridiska fakulteten vid Lunds universitet. Utöver sitt ordförandeskap, är han även verksam som advokat och delägare på advokatbyrån Vinge i Malmö. Erik Sjöman, som tog examen vid Juridiska fakulteten år 2000, är en av Sveriges mest fram

https://www.aclu.lu.se/en/article/chairperson-aclu-has-been-appointed-honoray-degree - 2025-04-01

Published 20 October 2022 The ACLU members Birgitta Nyström and Niklas Selberg have contributed to a new book entitled Anställningsskydd i utveckling Editing.: Niklas Selberg & Erik Sjödin Publication year: 2022 Book publisher: Iustus Förlag Introduction (Swedish) I Anställningsskydd i utveckling lämnas bidrag till fördjupad förståelse av en bred uppsättning anställningsskyddsrättsliga frågor – so

https://www.aclu.lu.se/en/article/new-book-anstallningsskydd-i-utveckling - 2025-04-01

Published 12 June 2022 Sacharias Votinius's book "Det samhällsbärande kontraktet" has been reviewed by Eric M Runesson in SvD Under Strecket Swedish Sacharias Votinius bok "Det samhällsbärande kontraktet" har blivit recenserad av justitierådet Eric M Runesson i SvD Under strecket. I texten "Konsten att få ett samhälle att hålla ihop" skriver Eric M Runesson bl.a. följande: På det sättet framstår e

https://www.aclu.lu.se/en/article/review-det-samhallsbarande-kontraktet-svd - 2025-04-01

Published 17 May 2022 The third publication in the ACLU writing series is now available for order. The overarching theme of the book is Changed Conditions. Swedish Under det senaste året har forskare och praktiker vid Affärsrättsligt Centrum vid Lunds universitet (ACLU) arbetat med tredje publikationen i ACLU:s skriftserie. Målsättningen för ACLU:s publikationer är att de ska belysa aktuella och p

https://www.aclu.lu.se/en/article/book-andrade-forhallanden-now-available-purchase - 2025-04-01

Published 19 January 2022 Håkan Hydén has written a new book that discusses the study of norms as a method of explaining human choice and behaviour. Author: Håkan Hydén, senior professor in sociology of law, Lund University Year of publication: 2021 Publishing house: Routledge  Abstract This book proposes the study of norms as a method of explaining human choice and behaviour by introducing a new

https://www.aclu.lu.se/en/article/new-book-sociology-law-science-norms - 2025-04-01

Published 19 May 2021 A warm welcome to doctoral student Jakob Hobér's presentation seminar on May 27 at 13.15-15.00! Swedish Jakob kommer att presentera sitt projekt som har den tentativa titeln ”Skuldebrevs cirkulering - En obligationsrättslig studie över överlåtelse och pantsättning av skuldebrev: särskilt om invändnings- och legitimationsrätten”. Anmäl dig till pernilla [dot] hakanssonpernilla

https://www.aclu.lu.se/en/article/jakob-hobers-presentation-seminar - 2025-04-01

Published 16 September 2019 Something to announce

https://www.cgbkansli.lu.se/en/article/testnews - 2025-04-01

Published 30 March 2015 Prof. Thoas Fioretos What is MAD for Cancer? In this 3-minute film you will understand more about the research focus in this multidisciplinary cancer program. Prof. Thoas Fioretos, Prof. Carl Borrebaeck and Prof. Kristian Pietras touches upon different research focus that is part of the program as well as share their vision of the program in this film.More information about

https://www.madforcancer.lu.se/article/short-film-about-mad-cancer - 2025-04-01

Published 12 April 2015 Micrograph of a carotid body in paraganglioma (Credits: Nephron, Wikimedia Commons) Sven Påhlman and MAD for Cancer recently recieved $2 million aiming to support Sven´s research for improving outcome for neuroendocrine cancers. A paraganglioma is a neuroendocrine type of tumor. It can develop at various body sites (including the head, neck, thorax and abdomen). The funding

https://www.madforcancer.lu.se/article/mad-cancer-recently-recieved-2-million - 2025-04-01

Published 12 May 2015 Nordea Masters is part of the prestigious PGA European Golf Tour. Last year, this event attracted 80.000 people at PGA Sweden National in Bara, outside of Malmö. This is one of the most anticipated golf competitions in Europe and will this June return to the PGA Sweden National in Bara. During Nordea Master 2014, MAD for Cancer at Lund University was the focus of a donation c

https://www.madforcancer.lu.se/article/mad-cancer-nordea-masters-4-7-june - 2025-04-01

Published 19 August 2015 STAT-3 structure (Credits: Wikimedia Commons) Researchers within MAD for Cancer recently published new results for the promising STAT3 inhibitor galiellalactone and its effect on prostate cancer This study shows that the STAT3 inhibitor galiellalactone reduces tumor growth and metastatic spread in an animal model of prostate cancer. The article “The STAT3 Inhibitor Galiell

https://www.madforcancer.lu.se/article/new-results-galiellalactone-and-its-effect-prostate-cancer - 2025-04-01

Published 9 October 2015 The US research institute, Rogosin Institute, invests in the Lund-based research program MAD for Cancer. The agreement gives the cancer research at Lund University new funds. Rogosin Institute has developed a general method to stop tumor growth, and the approach is to contain the tumor cells in particles of sugar and thereby produce proteins that stops the growth of tumor

https://www.madforcancer.lu.se/article/us-rogosin-institute-invests-mad-cancer - 2025-04-01

Published 8 February 2016 Pancreatic cancer cell Credit: STEVE GSCHMEISSNER / SCIENCE PHOTO LIBRARY / Universal Images Group Professor Kristian Pietras´ research group together with researchers at Karolinska Institute in Stockholm recently showed that it is only a small minority of tumor cells in neuroendocrine tumors of the pancreas that contribute to the entire tumor grow and spread. This findin

https://www.madforcancer.lu.se/article/minority-cancer-cells-can-contribute-entire-tumor-growth-pancreatic-cancer - 2025-04-01

Published 16 February 2016 Recently, the Lund University alumni Bertil P. Lundqvist, made a donation to the MAD for Cancer program, his American employer Starr Companies matched the amount. This procedure is called "Employee Matching Gift" and is a common form of philanthropic giving in the United States. This is the first time, Starr Companies give a donation to cancer research outside the US. Be

https://www.madforcancer.lu.se/article/us-based-starr-companies-made-donation-mad-cancer - 2025-04-01

Published 23 March 2016 Forskare från fyra fakulteter vid Lunds universitet samlar sin expertkunskap för att studera cancer ur flera perspektiv. Målet är bättre och tidigare metoder för diagnos och behandling, och att patienter snabbt ska gynnas av resultaten. Det så kallade MAD for Cancer-programmet får 2 miljoner kronor från Mats Paulssons stiftelse för forskning, innovation och samhällsbyggande

https://www.madforcancer.lu.se/article/donation-ger-skjuts-forskning-som-tar-helhetsgrepp-pa-tumorer - 2025-04-01

Published 6 April 2016 The patent application covers IL1RAP as a target molecule for antibody therapy and leukemia diagnostics. The IL1RAP originates from the research of Prof Thoas Fioretos. For more information

https://www.madforcancer.lu.se/article/cantargia-receives-patent-approval-japan-and-mexico - 2025-04-01

Published 8 April 2016 Based on recent results from retrospective studies, that are now under publication, we can differentiate the early resectable stages of pancreatic cancer, stage I and II, from the healthy controls with 96% accuracy. Read the article hear

https://www.madforcancer.lu.se/article/pancreatic-cancer-nordic-newsletter-includes-research-create-health - 2025-04-01